For research purposes only.
Peptide Mind does not endorse this protocol. This is a user-generated research reference — not for human consumption or therapeutic use.
Log your research schedule
Add this research protocol to your calendar or print a reference copy for your lab records. For research purposes only.
Peptide Protocol Schedule
A day-by-day view of this protocol. Tap any day to see which peptides are active. Circle size reflects how many peptides are scheduled; colored dots below represent individual peptides.
Off cycle
No peptides scheduled on this day.
Daily Dosing Breakdown
A grouped breakdown of which peptides to take throughout this protocol. Consecutive days with the same schedule are combined. Days with no doses are omitted.
Oct 6, 2026
GLP-3 (Retatrutide) — 4 mg ↑ · Morning
Oct 13, 2026
GLP-3 (Retatrutide) — 4 mg ↑ · Morning
Oct 20, 2026
GLP-3 (Retatrutide) — 4 mg ↑ · Morning
Oct 27, 2026
GLP-3 (Retatrutide) — 4 mg ↑ · Morning
Nov 2, 2026
Tesamorelin — 2 mg · Fasted
Nov 3, 2026
GLP-3 (Retatrutide) — 6 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Nov 4–6, 2026
Tesamorelin — 2 mg · Fasted
Nov 9, 2026
Tesamorelin — 2 mg · Fasted
Nov 10, 2026
GLP-3 (Retatrutide) — 6 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Nov 11–13, 2026
Tesamorelin — 2 mg · Fasted
Nov 16, 2026
Tesamorelin — 2 mg · Fasted
Nov 17, 2026
GLP-3 (Retatrutide) — 6 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Nov 18–20, 2026
Tesamorelin — 2 mg · Fasted
Nov 23, 2026
Tesamorelin — 2 mg · Fasted
Nov 24, 2026
GLP-3 (Retatrutide) — 6 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Nov 25–27, 2026
Tesamorelin — 2 mg · Fasted
Nov 30, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 1, 2026
GLP-3 (Retatrutide) — 8 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Dec 2, 2026
Tesamorelin — 2 mg · Fasted
Dec 3, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 4, 2026
Tesamorelin — 2 mg · Fasted
Dec 7, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 8, 2026
GLP-3 (Retatrutide) — 8 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Dec 9, 2026
Tesamorelin — 2 mg · Fasted
Dec 10, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 11, 2026
Tesamorelin — 2 mg · Fasted
Dec 14, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 15, 2026
GLP-3 (Retatrutide) — 8 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Dec 16, 2026
Tesamorelin — 2 mg · Fasted
Dec 17, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 18, 2026
Tesamorelin — 2 mg · Fasted
Dec 21, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 22, 2026
GLP-3 (Retatrutide) — 8 mg ↑ · Morning
Tesamorelin — 2 mg · Fasted
Dec 23, 2026
Tesamorelin — 2 mg · Fasted
Dec 24, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 25, 2026
Tesamorelin — 2 mg · Fasted
Dec 28, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Dec 29, 2026
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Dec 30, 2026
Tesamorelin — 2 mg · Fasted
Dec 31, 2026
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 1, 2027
Tesamorelin — 2 mg · Fasted
Jan 4, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 5, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Jan 6, 2027
Tesamorelin — 2 mg · Fasted
Jan 7, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 8, 2027
Tesamorelin — 2 mg · Fasted
Jan 11, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 12, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Jan 13, 2027
Tesamorelin — 2 mg · Fasted
Jan 14, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 15, 2027
Tesamorelin — 2 mg · Fasted
Jan 18, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 19, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Jan 20, 2027
Tesamorelin — 2 mg · Fasted
Jan 21, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 22, 2027
Tesamorelin — 2 mg · Fasted
Jan 25, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 26, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Jan 27, 2027
Tesamorelin — 2 mg · Fasted
Jan 28, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Jan 29, 2027
Tesamorelin — 2 mg · Fasted
Feb 1, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Feb 2, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Feb 3, 2027
Tesamorelin — 2 mg · Fasted
Feb 4, 2027
Tesamorelin — 2 mg · Fasted
MOTS-c — 3.75 mg · Morning
Feb 5, 2027
Tesamorelin — 2 mg · Fasted
Feb 8, 2027
Tesamorelin — 2 mg · Fasted
Feb 9, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Feb 10–12, 2027
Tesamorelin — 2 mg · Fasted
Feb 15, 2027
Tesamorelin — 2 mg · Fasted
Feb 16, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Feb 17–19, 2027
Tesamorelin — 2 mg · Fasted
Feb 22, 2027
Tesamorelin — 2 mg · Fasted
Feb 23, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Feb 24–26, 2027
Tesamorelin — 2 mg · Fasted
Mar 1, 2027
Tesamorelin — 2 mg · Fasted
Mar 2, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Mar 3–5, 2027
Tesamorelin — 2 mg · Fasted
Mar 8, 2027
Tesamorelin — 2 mg · Fasted
Mar 9, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Mar 10–12, 2027
Tesamorelin — 2 mg · Fasted
Mar 15, 2027
Tesamorelin — 2 mg · Fasted
Mar 16, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Mar 17–19, 2027
Tesamorelin — 2 mg · Fasted
Mar 22, 2027
Tesamorelin — 2 mg · Fasted
Mar 23, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Mar 24–26, 2027
Tesamorelin — 2 mg · Fasted
Mar 29, 2027
Tesamorelin — 2 mg · Fasted
Mar 30, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Mar 31 – Apr 2, 2027
Tesamorelin — 2 mg · Fasted
Apr 5, 2027
Tesamorelin — 2 mg · Fasted
Apr 6, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Apr 7–9, 2027
Tesamorelin — 2 mg · Fasted
Apr 12, 2027
Tesamorelin — 2 mg · Fasted
Apr 13, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Apr 14–16, 2027
Tesamorelin — 2 mg · Fasted
Apr 19, 2027
Tesamorelin — 2 mg · Fasted
Apr 20, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Apr 21–23, 2027
Tesamorelin — 2 mg · Fasted
Apr 26, 2027
Tesamorelin — 2 mg · Fasted
Apr 27, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
Apr 28–30, 2027
Tesamorelin — 2 mg · Fasted
May 3, 2027
Tesamorelin — 2 mg · Fasted
May 4, 2027
GLP-3 (Retatrutide) — 10 mg · Morning
Tesamorelin — 2 mg · Fasted
May 5–7, 2027
Tesamorelin — 2 mg · Fasted
May 10–14, 2027
Tesamorelin — 2 mg · Fasted
May 17–21, 2027
Tesamorelin — 2 mg · Fasted
Weekly Schedule
Day-of-week breakdown for each peptide in this protocol.
GLP-3
GLP-3 (Retatrutide)
morning
subcutaneous
4 mg
- Starting Dose
- 4 mg
- Step
- +2 mg every 4 weeks
- Max Dose
- 10 mg
- Cycle Duration
- 30 weeks 6 days
tesa
Tesamorelin
fasted
subcutaneous
2 mg
- Cycle Duration
- 28 weeks 6 days
mot
MOTS-c
morning
subcutaneous
3.75 mg
- Cycle Duration
- 9 weeks 6 days
Total Peptide Requirements
The total quantity of each peptide needed to complete this protocol, calculated from dosage and duration.
Weight
GLP-3
Metabolic
GLP-3 (Retatrutide)
4–10 mg · weekly · Morning
Weight
tesa
Growth
Tesamorelin
2 mg · 5× weekly · Fasted
Metabolic
mot
Metabolic
MOTS-c
3.8 mg · twice weekly · Morning
Know exactly what to draw
Enter your vial concentration and we'll calculate the precise injection volume for every peptide in this protocol.
Protocol Body Targets
The biological systems and tissue targets addressed by the 3 peptides in this protocol.
4
Body Targets
3 peptides
Metabolic
Regulates fat metabolism, insulin sensitivity, and energy use.
GLP-3 (Retatrutide), Tesamorelin, MOTS-c
Gut
Supports gut lining integrity, digestion, and the gut-brain axis.
GLP-3 (Retatrutide)
Hormones
Influences hormone signaling pathways and endocrine balance.
Tesamorelin
Muscle
Enhances muscle growth, repair, and recovery after exercise.
MOTS-c
Protocol targeted areas
Build your own protocol
Create a custom peptide stack tailored to your goals. Add peptides, set dosages, and share it with the community.
Protocol Duration & Timeline
A visual breakdown of each peptide's active window within this protocol. Use this to understand the total cycle length and how each compound's duration compares to the full protocol.
GLP-3 (Retatrutide)
4 mg once per week
Start at 4 mg · +2 mg every 4 weeks · max 10 mg
- 216 days
Tesamorelin
2 mg 5x per week
- 202 days
MOTS-c
3.75 mg twice per week
- 69 days
Protocol Peptides
Each peptide included in this protocol with its dosing amount, frequency, and administration details.
Weight
GLP-3
Metabolic
Weight
tesa
Growth
Frequently asked questions
What is a peptide dosage calculator?
A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringe units to draw. This calculator works for single peptide compounds and multi-peptide blends.
How do I calculate peptide dosage from a vial?
To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.
How much Bacteriostatic water should I add to a peptide vial?
Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.
How are peptides different from proteins?
Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.